Metropolitan Life Insurance Company (MetLife)’s Fennec Pharmaceuticals FENC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,003
| Closed | -$11.2K | – | 756 |
|
|
2024
Q1 | $11.2K | Hold |
1,003
| – | – | ﹤0.01% | 2095 |
|
|
2023
Q4 | $11.3K | Hold |
1,003
| – | – | ﹤0.01% | 2145 |
|
|
2023
Q3 | $7.53K | Hold |
1,003
| – | – | ﹤0.01% | 2332 |
|
|
2023
Q2 | $8.86K | Buy |
+1,003
| New | +$8.86K | ﹤0.01% | 2363 |
|
|
2020
Q3 | – | Sell |
-7,824
| Closed | -$65.3K | – | 2574 |
|
|
2020
Q2 | $65.3K | Buy |
+7,824
| New | +$65.3K | ﹤0.01% | 2463 |
|